Linear immunoglobulin A bullous dermatosis.

[1]  A. Pandya,et al.  Drug-induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon. , 2010, Journal of the American Academy of Dermatology.

[2]  D. Zillikens,et al.  Linear IgA Disease: Successful Application of Immunoadsorption and Review of the Literature , 2010, Dermatology.

[3]  K. Takatsu,et al.  IL-5- and eosinophil-mediated inflammation: from discovery to therapy. , 2009, International immunology.

[4]  M. Pavlović,et al.  Linear IgA bullous dermatosis of childhood: successful treatment with miocamycin and topical corticosteroid , 2009, Clinical and experimental dermatology.

[5]  P. Filipe,et al.  Autoimmune Bullous Dermatoses: A Review , 2009, Annals of the New York Academy of Sciences.

[6]  S. Curran,et al.  Drug‐associated linear IgA disease mimicking toxic epidermal necrolysis , 2009, Clinical and experimental dermatology.

[7]  Claus-Werner Franzke,et al.  Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97. , 2009, The Journal of investigative dermatology.

[8]  Sarah N. Walsh,et al.  Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels. , 2009, Archives of dermatology.

[9]  E. Bröcker,et al.  Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[10]  D. Waugh,et al.  The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.

[11]  M. Caproni,et al.  Linear IgA disease and desquamative gingivitis: time for inclusion in mucous membrane pemphigoid. , 2008, Oral diseases.

[12]  Y. Horiguchi,et al.  Linear IgA dermatosis: Report of an infantile case and analysis of 213 cases in Japan , 2008, The Journal of dermatology.

[13]  R. El-Azhary,et al.  A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis. , 2008, Archives of dermatology.

[14]  P. Saiag,et al.  Tacrolimus ointment, an interesting adjunctive therapy for childhood linear IgA bullous dermatosis , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[15]  G. Tobón,et al.  Linear IgA bullous dermatosis associated with systemic lupus erythematosus: a case report , 2008, Clinical Rheumatology.

[16]  J. Browning,et al.  Dermatitis herpetiformis: potential for confusion with linear IgA bullous dermatosis on direct immunofluorescence. , 2008, Dermatology online journal.

[17]  L. Chan,et al.  Linear IgA bullous dermatosis responsive to trimethoprim–sulfamethoxazole , 2007, Clinical and experimental dermatology.

[18]  F. Wojnarowska,et al.  Dermal‐binding linear IgA disease: an uncommon subset of a rare immunobullous disease , 2007, Clinical and experimental dermatology.

[19]  N. Sepp,et al.  Vancomycin‐induced linear IgA bullous dermatosis in an immunosuppressed transplant recipient , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[20]  K. Yoneda,et al.  Localized linear IgA disease showing contact dermatitis-like eruption. , 2007, European journal of dermatology : EJD.

[21]  L. Geng,et al.  Localized linear IgA dermatosis induced by UV light‐treatment for herpes zoster , 2007, International journal of dermatology.

[22]  A. Nanda,et al.  Linear IgA Bullous Disease of Childhood: An Experience from Kuwait , 2006, Pediatric dermatology.

[23]  E. Bröcker,et al.  Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients , 2006, International journal of dermatology.

[24]  M. Caproni,et al.  Linear IgA disease presenting as prurigo nodularis , 2006, The British journal of dermatology.

[25]  C. Talhari,et al.  Ocular linear IgA disease resulting in blindness. , 2006, Archives of dermatology.

[26]  I. Hamadah,et al.  Treatment of linear IgA bullous dermatosis of childhood with flucloxacillin. , 2006, Journal of the American Academy of Dermatology.

[27]  M. Pittelkow,et al.  Paraneoplastic autoimmune multiorgan syndrome: Review of the literature and support for a cytotoxic role in pathogenesis , 2006, Autoimmunity.

[28]  Z. Werb,et al.  Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. , 2005, The Journal of clinical investigation.

[29]  K. Yancey.  The pathophysiology of autoimmune blistering diseases. , 2005, The Journal of clinical investigation.

[30]  H. Hanazawa,et al.  Initial presentation and fatal complications of linear IgA bullous dermatosis in the larynx and pharynx , 2005, The Journal of Laryngology & Otology.

[31]  A. Nanda,et al.  Spectrum of autoimmune bullous diseases in Kuwait , 2004, International journal of dermatology.

[32]  A. Kanwar,et al.  CHRONIC BULLOUS DERMATOSIS OF CHILDHOOD IN NORTH INDIA , 2004, Pediatric dermatology.

[33]  J. Child,et al.  Linear IgA disease in association with chronic lymphocytic leukaemia , 2004, The British journal of dermatology.

[34]  D. Thompson,et al.  Upper aerodigestive tract complications in a neonate with linear IgA bullous dermatosis. , 2004, International journal of pediatric otorhinolaryngology.

[35]  G. Scott,et al.  A successful challenge in a patient with vancomycin-induced linear IgA dermatosis. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[36]  J. Uitto,et al.  Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype , 2004, International journal of dermatology.

[37]  S. A. Spencer,et al.  Home phototherapy in the United Kingdom , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[38]  M. Toner,et al.  Linear IgA disease presenting as desquamative gingivitis: a pattern poorly recognized in medicine. , 2004, Archives of otolaryngology--head & neck surgery.

[39]  F. Wojnarowska,et al.  Linear IgA disease: the IgA and IgG response to dermal antigens demonstrates a chiefly IgA response to LAD285 and a dermal 180‐kDa protein , 2003, The British journal of dermatology.

[40]  A. Mancini,et al.  Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil. , 2003, Archives of dermatology.

[41]  J. M. A. Urízar,et al.  Two cases of linear IgA disease with clinical manifestations limited to the gingiva. , 2003, Journal of periodontology.

[42]  F. Wojnarowska,et al.  The cellular origins of the linear IgA disease target antigens: an indirect immunofluorescence study using cultured human keratinocytes and fibroblasts , 2003 .

[43]  R. Vodegel,et al.  IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. , 2002, Journal of the American Academy of Dermatology.

[44]  F. Wojnarowska,et al.  Linear IgA disease: successful treatment with erythromycin , 2002, Clinical and experimental dermatology.

[45]  S. Chua,et al.  Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2‐year review , 2002, The British journal of dermatology.

[46]  D. Zillikens,et al.  Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule. , 2002, Clinical immunology.

[47]  L. Davis,et al.  Localized linear IgA disease responding to colchicine , 2002, International journal of dermatology.

[48]  E. Beutner,et al.  Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature. , 2001, Journal of the American Academy of Dermatology.

[49]  G. Ogg,et al.  Vancomycin‐induced linear IgA disease with autoantibodies to BP180 and LAD285 , 2001, The British journal of dermatology.

[50]  M. Marinkovich,et al.  Linear IgA bullous dermatosis. , 2001, Clinics in dermatology.

[51]  R. Pandhi,et al.  Response of chronic bullous dermatosis of childhood to a combination of dapsone and nicotinamide , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

[52]  E. Bröcker,et al.  Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease , 2001, Archives of Dermatological Research.

[53]  J. Ryan,et al.  The role of Th2 cytokines in mast cell homeostasis , 2001, Immunological reviews.

[54]  M. Deleuran,et al.  Multiple trichoepithelioma with secondary localized amyloidosis , 2000, The British journal of dermatology.

[55]  L. Girão,et al.  Burn‐induced linear IgA dermatosis , 2000, Journal of the European Academy of Dermatology and Venereology : JEADV.

[56]  M. Davis,et al.  Naproxen-associated linear IgA bullous dermatosis: case report and review. , 2000, Mayo Clinic proceedings.

[57]  Z. Werb,et al.  The Serpin α1-Proteinase Inhibitor Is a Critical Substrate for Gelatinase B/MMP-9 In Vivo , 2000, Cell.

[58]  C. Foster,et al.  Linear IgA bullous disease limited to the eye: a diagnostic dilemma: response to intravenous immunoglobulin therapy. , 2000, Ophthalmology.

[59]  I. Coulson,et al.  Linear IgA disease: successful treatment with cyclosporin , 2000, The British journal of dermatology.

[60]  W. Fujimoto,et al.  Linear IgA disease with IgA antibodies directed against 200‐ and 280‐kDa epidermal antigens , 2000, The British journal of dermatology.

[61]  J. Bong,et al.  Is systemic autoimmune disease a risk factor for terbinafine‐induced erythema multiforme? , 2000, The British journal of dermatology.

[62]  J. Callen,et al.  Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. , 2000, Journal of the American Academy of Dermatology.

[63]  Justine R Smith Mbbs Fracs,et al.  Linear IgA disease. , 1999, Australian and New Zealand journal of ophthalmology.

[64]  M. Black,et al.  Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression , 1999, The British journal of dermatology.

[65]  J. Zone,et al.  Linear IgA bullous dermatosis , 1999, International journal of dermatology.

[66]  S. Jabłońska,et al.  THE THERAPIES FOR LINEAR IgA BULLOUS DERMATOSIS OF CHILDHOOD , 1999, Pediatric dermatology.

[67]  J. Zone,et al.  IgA antibodies recognizing LABD97 are predominantly IgA1 subclass. , 1999, Acta dermato-venereologica.

[68]  W. Pichler,et al.  Drug-Induced Linear IgA Bullous Dermatosis Associated with Ceftriaxone- and Metronidazole-Specific T Cells , 1999, Dermatology.

[69]  Bianchi,et al.  The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis , 1999, The British journal of dermatology.

[70]  E. Siegfried,et al.  Chronic bullous disease of childhood: successful treatment with dicloxacillin. , 1998, Journal of the American Academy of Dermatology.

[71]  Allen,et al.  The localization of target antigens and autoantibodies in linear IgA disease is variable: correlation of immunogold electron microscopy and immunoblotting , 1998, The British journal of dermatology.

[72]  J. Ogunbiyi,et al.  Nevus depigmentosus and inflammatory linear epidermal nevus – an unusual combination with a note on histology , 1998, International journal of dermatology.

[73]  H. Shimizu,et al.  97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen. , 1998, The Journal of investigative dermatology.

[74]  Mengel,et al.  Desquamative gingivitis and balanitis — linear IgA disease or cicatricial pemphigoid? , 1998, Clinical and experimental dermatology.

[75]  M. Camilleri,et al.  Drug-induced linear immunoglobulin-A bullous dermatosis. , 1998, Clinics in dermatology.

[76]  J. Usukura,et al.  Cleavage of BP180, a 180-kDa Bullous Pemphigoid Antigen, Yields a 120-kDa Collagenous Extracellular Polypeptide* , 1998, The Journal of Biological Chemistry.

[77]  E. Bröcker,et al.  Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801. , 1998, The Journal of investigative dermatology.

[78]  J. Zone,et al.  The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. , 1998, The Journal of investigative dermatology.

[79]  M. Insler,et al.  Mucocutaneous features of autoimmune blistering diseases. , 1997, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[80]  F. Wojnarowska,et al.  Linear IgA disease: a report of two dermal binding sera which recognize a pepsin‐sensitive epitope (?NC‐1 domain) of collagen type VII , 1997, The British journal of dermatology.

[81]  Sudha K. Rao,et al.  LAD-1 is absent in a subset of junctional epidermolysis bullosa patients. , 1997, The Journal of investigative dermatology.

[82]  S. Chandi,et al.  Linear IgA bullous dermatosis of childhood: treatment with dapsone and co‐trimoxazole , 1997, Clinical and experimental dermatology.

[83]  J. Roujeau,et al.  Drug‐induced linear IgA disease: target antigens are heterogeneous , 1997, The British journal of dermatology.

[84]  A. Concha,et al.  Linear IgA disease in a patient with bladder carcinoma , 1997, The British journal of dermatology.

[85]  Y. Yamane,et al.  Linear immunoglobulin A (IgA) bullous dermatosis of childhood: identification of the target antigens and study of the cellular sources , 1996, The British journal of dermatology.

[86]  J. Zone,et al.  IgA antibodies in chronic bullous disease of childhood react with 97 kDa basement membrane zone protein. , 1996, The Journal of investigative dermatology.

[87]  R. Burgeson,et al.  LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. , 1996, The Journal of investigative dermatology.

[88]  T. Traczyk,et al.  Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies. , 1995 .

[89]  P. Isaacs,et al.  Linear IgA dermatosis, coeliac disease, and extraintestinal B cell lymphoma. , 1995, Gut.

[90]  E. Bröcker,et al.  Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. , 1995, Archives of dermatology.

[91]  P. Millard,et al.  The localization of the target antigens and antibodies in linear IgA disease is heterogeneous, and dependent on the methods used , 1995, The British journal of dermatology.

[92]  A. Giannetti,et al.  Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. , 1994, Journal of the American Academy of Dermatology.

[93]  M. Black,et al.  Chronic bullous disease of childhood and linear IgA disease of adults are IgA1‐mediated diseases , 1994, The British journal of dermatology.

[94]  Jean Kanitakis,et al.  Linear IgA Bullous Dermatosis of Childhood with Autoantibodies to a 230 kDa Epidermal Antigen , 1994, Pediatric dermatology.

[95]  F. Wojnarowska,et al.  Linear IgA disease and pregnancy. , 1994, Journal of the American Academy of Dermatology.

[96]  T. Nishikawa,et al.  Immunoblotting studies of linear IgA disease. , 1993, Journal of dermatological science.

[97]  D. Schadendorf,et al.  Human mast cells produce IL-8. , 1993, Journal of immunology.

[98]  Jin Peiying,et al.  CHRONIC BULLOUS DERMATOSES IN CHINA , 1993 .

[99]  Y. Murata,et al.  Immunoelectronmicroscopic differentiation of linear IgA bullous dermatosis of adults with coexistence of IgA and IgG deposition from bullous pemphigoid. , 1992, Journal of the American Academy of Dermatology.

[100]  P. Plantin,et al.  Association d'une dermatose à IgA linéaire et d'un lymphome malin non hodgkinien , 1992 .

[101]  S. Jabłońska,et al.  Linear IgA bullous dermatosis of childhood (chronic bullous dermatosis of childhood). , 1991, Clinics in dermatology.

[102]  B. Bhogal,et al.  Chronic bullous dermatosis of childhood–clinical and immunological features seen in African patients , 1991, Clinical and experimental dermatology.

[103]  I. Leigh,et al.  Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults , 1991, The British journal of dermatology.

[104]  F. Wojnarowska,et al.  Chronic bullous disease of childhood with oral mucosal scarring , 1991, Clinical and experimental dermatology.

[105]  D. Belin,et al.  mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. , 1990, The Journal of investigative dermatology.

[106]  F. Wojnarowska,et al.  Chronic bullous disease of childhood in three patients of Polynesian extraction , 1990, Clinical and experimental dermatology.

[107]  P. H. Mckee,et al.  Use of 1M NaCl split skin in the indirect immunofluorescence of the linear IgA bullous dermatoses , 1990, Journal of cutaneous pathology.

[108]  J. Zone,et al.  Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. , 1990, The Journal of clinical investigation.

[109]  J. Regezi,et al.  Oral manifestations of linear IgA disease. , 1990, Journal of the American Academy of Dermatology.

[110]  J. Mcfadden,et al.  Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid , 1989, The British journal of dermatology.

[111]  F. Wojnarowska,et al.  Chronic Bullous Dermatosis of Childhood Persisting into Adulthood , 1988, Pediatric dermatology.

[112]  M. Black,et al.  Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. , 1988, Journal of the American Academy of Dermatology.

[113]  C. Apovian,et al.  Vancomycin-induced linear IgA bullous dermatosis , 1988 .

[114]  P. Jensen,et al.  Epidermal plasminogen activator is abnormal in cutaneous lesions. , 1988, The Journal of investigative dermatology.

[115]  R. Senior,et al.  The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant , 1988, The Journal of experimental medicine.

[116]  E. Donnenfeld,et al.  Linear IgA Disease , 1988 .

[117]  F. Wojnarowska,et al.  Distribution of the antigen in adult linear IgA disease and chronic bullous dermatosis of childhood suggests that it is a single and unique antigen , 1988, The British journal of dermatology.

[118]  K. Ratnam.  IgA Dermatosis in an Adult Chinese Population , 1988, International journal of dermatology.

[119]  P. H. Mckee,et al.  Linear IgA bullous dermatosis of adults and children: an immunoelectron microscopic study , 1987, The British journal of dermatology.

[120]  M. Black,et al.  A clinicopathological study of mucosal involvement in linear IgA disease , 1987, The British journal of dermatology.

[121]  F. Verhelst,et al.  Adult linear IgA bullous dermatosis with bronchial involvement , 1987, The British journal of dermatology.

[122]  C. T. Lee,et al.  Chronic Bullous Dermatosis of Childhood in Singapore , 1986, International journal of dermatology.

[123]  E. Holborow,et al.  Evidence that the IgA in patients with linear IgA disease is qualitatively different from that of patients with dermatitis herpetiformis , 1984, The British journal of dermatology.

[124]  A. Inman,et al.  Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. , 1984, The Journal of investigative dermatology.

[125]  E. Berti,et al.  Small‐Bowel Involvement in Dermatitis Herperiformis and in Linear‐IgA Bullous Dermatosis , 1983, Journal of clinical gastroenterology.

[126]  J. Schiffner.  Therapy of childhood linear IgA dermatitis herpetiformis. , 1982, Journal of the American Academy of Dermatology.

[127]  Kunihiko Hashimoto,et al.  HLA ANTIGENS IN DERMATITIS HERPETIFORMIS AMONG JAPANESE , 1980, The Journal of dermatology.

[128]  P. H. Mckee,et al.  A study of benign chronic bullous dermatosis of childhood and comparison with dermatitis herpetiformis and bullous pemphigoid occurring in childhood , 1980, Clinical and experimental dermatology.

[129]  F. Wojnarowska.  Linear IgA Dapsone Responsive Bullous Dermatosis 1 , 1980, Journal of the Royal Society of Medicine.

[130]  S. Jabłońska,et al.  IgA linear dermatosis of childhood (chronic Bullous disease of childhood) , 1979, The British journal of dermatology.

[131]  S. Jabłońska,et al.  Immunoelectron microscopic studies in IgA linear dermatosis , 1979, Archives of Dermatological Research.

[132]  W. Lobitz,et al.  The enigma of bullous pemphigoid and dermatitis herpetiformis. , 1972, Archives of dermatology.

[133]  R. Winkelmann,et al.  Childhood bullous dermatitis herpetiformis. Negative immunofluorescent tests. , 1970, Archives of dermatology.

[134]  R. Winkelmann,et al.  Dermatitis herpetiformis in children. Relationship to bullous pemphigoid. , 1961 .

[135]  R. Schneiderman,et al.  Dermatitis herpetiformis; specific entity or clinical complex. , 1959, The Journal of investigative dermatology.

[136]  C. Berlin.  DERMATITIS HERPETIFORMIS IN CHILDREN , 1952, The British journal of dermatology.

[137]  C. Belajouza,et al.  Childhood Linear IgA Bullous Dermatosis in Tunisia , 2009, Pediatric dermatology.

[138]  Y. de Prost,et al.  Linear Iga Dermatosis , 2007 .

[139]  Y. Okayama,et al.  Development, migration, and survival of mast cells , 2006, Immunologic research.

[140]  C. Talhari,et al.  Ocular linear IgA disease resulting in blindness. Commentary , 2006 .

[141]  J. Zone,et al.  IgA autoimmune disorders: development of a passive transfer mouse model. , 2004, The journal of investigative dermatology. Symposium proceedings.

[142]  J. A. Aguirre Urízar,et al.  Oral manifestations caused by the linear IgA disease. , 2004, Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal.

[143]  Clinical and Laboratory Investigations Linear IgA disease: the IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults , 2003 .

[144]  Y. Tay,et al.  Treatment of Linear IgA Bullous Dermatosis of Childhood with Colchicine , 1999, Pediatric dermatology.

[145]  L. Vaillant,et al.  Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. , 1995, Archives of dermatology.

[146]  L. Vaillant,et al.  Incidence and Distribution of Subepidermal Autoimmune Bullous Skin Diseases in Three French Regions , 1995 .

[147]  K. Ayed,et al.  [Iga linear bullous dermatosis in children. A series of 12 Tunisian patients]. , 1994, Annales de dermatologie et de venereologie.

[148]  F. Wojnarowska,et al.  Molecular overlap of the IgA target antigens in the subepidermal blistering diseases. , 1994, Dermatology.

[149]  N. Pimpinelli,et al.  A peculiar case of linear IgA bullous dermatosis. , 1991, Archives of dermatology.

[150]  L. Dubertret,et al.  Diagnosis of adult linear IgA dermatosis by immunoelectronmicroscopy in 16 patients with linear IgA deposits. , 1989, The Journal of investigative dermatology.

[151]  E. Beutner,et al.  Dermatitis herpetiformis and bullous pemphigoid. Intermediate and mixed forms. , 1976, Archives of dermatology.